Tag: SMA Foundation

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to SMA Foundation

New two-year data show Roche's Evrysdi (risdiplam) continues to demonstrate improvement or ...

Added to Collection on: 2021-03-16 06:00:00

Tags for this article:

Neurological disorders
Health
Clinical research
Motor neuron diseases
Design of experiments
Orphan drugs
Risdiplam
PTC Therapeutics
Placebo
Spinal muscular atrophies
Clinical trial
Hoffmann-La Roche
SMA Foundation
Roche Group
Basel

Click the tags to see associated articles and topics

View Article Details
Health Canada provides update on safety review of AstraZeneca and COVISHIELD COVID-19 ...

Added to Collection on: 2021-04-14 15:35:37

Tags for this article:

Neurological disorders
Neurodegenerative disorders
Motor neuron diseases
Orphan drugs
Risdiplam
PTC Therapeutics
Spinal muscular atrophies
SMA Foundation
Roche Group
Basel

Click the tags to see associated articles and topics

View Article Details
Roche's Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal ...

Added to Collection on: 2021-04-15 04:52:30

Tags for this article:

Neurological disorders
Neurodegenerative disorders
Motor neuron diseases
Orphan drugs
Risdiplam
PTC Therapeutics
Spinal muscular atrophies
SMA Foundation
Roche Group
Basel

Click the tags to see associated articles and topics

View Article Details
New Roche data for Evrysdi show improved motor function in pre-symptomatic babies after one ...

Added to Collection on: 2021-06-11 04:52:30

Tags for this article:

Spinal muscular atrophy
Orphan drugs
Health sciences
Drugs
Health
Risdiplam
Onasemnogene abeparvovec
Nusinersen
PTC Therapeutics
Hoffmann-La Roche
SMA Foundation
United States
Roche Group

Click the tags to see associated articles and topics

View Article Details
Japan Approves Evrysdi as First At-home, Oral SMA Treatment

Added to Collection on: 2021-06-25 15:45:00

Tags for this article:

Neurological disorders
Neurodegenerative disorders
Spinal muscular atrophy
Orphan drugs
PTC Therapeutics
Risdiplam
Genentech
SMA Foundation
Japan

Click the tags to see associated articles and topics

View Article Details
Data for Genentech's Evrysdi (risdiplam) Published in New England Journal of Medicine Shows ...

Added to Collection on: 2021-07-28 21:00:00

Tags for this article:

Neurological disorders
Neurodegenerative disorders
Motor neuron diseases
Orphan drugs
SMA
Risdiplam
Infant
Spinal muscular atrophies
Survival of motor neuron
SOUTH SAN FRANCISCO
SMA Foundation
Genentech
Roche Group

Click the tags to see associated articles and topics

View Article Details
Roche gets FDA priority review for Evrysdi to treat SMA in new-borns

Added to Collection on: 2022-01-27 11:17:19

Tags for this article:

Spinal muscular atrophy
Neurological disorders
Drugs
Orphan drugs
Health sciences
Risdiplam
PTC Therapeutics
SMA
New Drug Application
SMA Foundation

Click the tags to see associated articles and topics

View Article Details
Roche Evrysdi improves/maintains motor function in SMA patients in new 2-year data

Added to Collection on: 2022-10-12 09:05:42

Tags for this article:

Neurological disorders
Spinal muscular atrophy
Neurodegenerative disorders
Nusinersen
Onasemnogene abeparvovec
Survival of motor neuron
Risdiplam
SMA
Epigenetics of neurodegenerative diseases
SMA Foundation
Microbe Roche

Click the tags to see associated articles and topics

View Article Details
PTC Therapeutics falls as partner Roche reports Q3 sales for SMA therapy - Seeking Alpha

Added to Collection on: 2022-10-18 18:10:02

Tags for this article:

Neurological disorders
Neurodegenerative disorders
Spinal muscular atrophy
RTT
OTC Markets Group
PTC Therapeutics
SMA Foundation

Click the tags to see associated articles and topics

View Article Details